The launch in Thailand marks Wegovy’s entry into the Southeast Asian market. Enrico Canal Bruland, vice president and general manager of Novo's Thai subsidiary, told Reuters that the firm ...

Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's local subsidiary said on Monday, marking the injectable drug's first entry ...

The hugely popular medications Ozempic and Wegovy , used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.

Novo Nordisk, the maker of Wegovy, announced exclusively on "Good Morning America" Tuesday that the medication will soon be available for purchase through the telehealth companies Ro, Hims and ...

The Danish drugmaker Novo Nordisk announced it has temporarily reduced the price of the weight-loss drug Wegovy for new customers as it attempts to limit sales of compounded versions of the ...

Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy will have the option to buy now and pay later under a partnership announced Tuesday by ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are now. By Rebecca Robbins It’s easy to make a medical case for ...

Ozempic and Wegovy are made by Novo Nordisk, which is based in Denmark and has U.S. headquarters Plainsboro, New Jersey. Originally Published: January 17, 2025 at 10:45 AM CST.

Wegovy is a brand-name subcutaneous injection prescribed for weight loss and reduction of cardiovascular risks. Its cost with and without insurance can depend on several factors, such as whether ...

The weight-loss drug Wegovy has been bombarding TV commercial breaks with ads, more than a year after its manufacturer, Novo Nordisk, limited starter-dose supplies in the U.S. to get a handle on ...

BANGKOK (Reuters) -Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's local subsidiary said on Monday, marking the injectable drug ...